What is ANIK's P/E ratio?

ANIKA THERAPEUTICS INC (ANIK) currently trades at a P/E ratio of 659.81.

ANIKA THERAPEUTICS INC reports a Return on Equity (ROE) of -8.26%.

What is ANIK's dividend yield?

ANIKA THERAPEUTICS INC offers a dividend yield of 0.00%.

What is ANIK's Deepscope Quality Score?

Deepscope rates ANIK's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ANIK?

Deepscope's AI Timing Score for ANIK is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ANIK belong to?

ANIKA THERAPEUTICS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

ANIK (NASDAQ) Stock Analysis | ANIKA THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-08 | FS: 2026-03-31)

ANIK

ANIKA THERAPEUTICS INC

USD 14.60

0.12 (0.83%) Day Change

Watchlist Portfolio Compare Chart

659.81

P/E

0.01

D/E

-8.3%

ROE

-6.2%

ROA

0.00%

Div Yield

5.81

PEG

ANIKA THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 14.60 Price 0.12 (0.83%) Day Change	NEWS SCORE: 95

ANIK, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	95
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	14.60
PBV / Sector	1.44 / 2.63 GOOD
Earning Per Share	-0.84

PE / Sector	659.81 / 23.62
PEG or PE/Growth / Sector	5.81 / 0.12
Average 1M Daily Value	1.00 M GREAT
Average 1W Daily Value	0.77 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-9.52 / 15.98
NPM Average (%) / Sector	-28.83 / -16.38
NPM Change Average (%) / Sector	126.87 / 113.39 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-6.17 / 8.16
ROA Average (%) / Sector	-14.90 / 2.38
ROA Change Average (%) / Sector	134.29 / 108.63 GREAT
ROE (%) / Sector	-8.26 / -0.19
ROE Average (%) / Sector	-19.32 / 7.40
ROE Change Average (%) / Sector	143.03 / 371.95 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.53
Dividend Average (%) / Sector	N/A / 3.08
Dividend Change Average (%) / Sector	N/A / 14.92

Registration Details

Analyze Date	2026-06-09 09:40:05
Symbol	ANIK
Name	ANIKA THERAPEUTICS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	13.31 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	192.67 / 9,799.42

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 32 Wiggins Avenue, Bedford, MA, United States, 01730

Phone: 781 457 9000

Website: https://www.anika.com

Employees: 235

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.